<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99163">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01937858</url>
  </required_header>
  <id_info>
    <org_study_id>RC08/107/A</org_study_id>
    <nct_id>NCT01937858</nct_id>
  </id_info>
  <brief_title>The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure</brief_title>
  <official_title>The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reem Mohammad Alamoudi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Abdullah International Medical Research Center</source>
  <oversight_info>
    <authority>Saudi Arabia: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The value of HbA1c as a tool to determine glycemic control in patients with diabetes and
      renal failure has not been well studied, the same accepted normal ranges for HbA1c are
      applied to all patients with diabetes regardless of their renal function. We would like to
      evaluate the use of HbA1c as a tool of assessing long term glycemic control in this subgroup
      of patients with diabetes and evaluate the effect of dialysis on HbA1c
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Correlation</measure>
    <time_frame>three months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The quantitative correlation between mean blood glucose and HbA1c in patients with diabetes and renal failure</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Diabetes</condition>
  <condition>Renal Failure</condition>
  <arm_group>
    <arm_group_label>Normal renal function</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Stage 2 and 4 and 5 chronic kidney disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>End stage renal disease on hemodialysis</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Our target population is patients with diabetes and impaired renal function. This study
        will include 80 adult patients with type1 or type 2 diabetes; 20 with normal serum
        creatinine, 40 with renal failure in the predialysis stage (20 with stage 3 and 4 CKD [GFR
        0f 20-40] and 20 with stage 5 CKD not yet on hemodialysis [GFR &lt;20]), and 20 on
        hemodialysis. All patients should be comfortable and committed to doing self-glucose
        monitoring.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All patients &gt;18 years of age with type 1 or 2 diabetes who show competence in home
        glucose monitoring and are willing to commit to doing the testing

        Exclusion Criteria:

          -  Pregnancy

          -  Having received a blood transfusion with in the preceding three months

          -  Known to have any hereditary or hemolytic anemia

          -  On a medication known to interfere with HbA1c assay (opiates, acetaminophen, vitamin
             C, vitamin E) - we will allow patients to be on asprin as almost all patients with
             diabetes are on this drug.

          -  Having a blood hemoglobin &lt;7 mg/dl

          -  Bilirubin level &gt;20mg/dL or a triglyceride level &gt; 250mg/dL

          -  Alcohol addiction
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>King Abdulaziz National Guards Hospital</name>
      <address>
        <city>Al-Ahsa</city>
        <zip>31982</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzan Aloraibi</last_name>
      <phone>+966-13-5910000</phone>
      <phone_ext>36289</phone_ext>
      <email>OraibiS@NGHA.MED.SA</email>
    </contact>
    <contact_backup>
      <last_name>Reem Alamoudi</last_name>
      <phone>+966-13-8581111</phone>
      <phone_ext>31504</phone_ext>
      <email>amoudir@ngha.med.sa</email>
    </contact_backup>
    <investigator>
      <last_name>Reem M Alamoudi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 4, 2013</lastchanged_date>
  <firstreceived_date>September 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>King Abdullah International Medical Research Center</investigator_affiliation>
    <investigator_full_name>Reem Mohammad Alamoudi</investigator_full_name>
    <investigator_title>Consultant Endocrinology</investigator_title>
  </responsible_party>
  <keyword>HbA1c</keyword>
  <keyword>glycated hemoglobin</keyword>
  <keyword>correlation</keyword>
  <keyword>diabetes</keyword>
  <keyword>renal failure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
